BioXcel Therapeutics (BTAI) Announces Clinical Prioritization and Update on BXCL501

Go back to BioXcel Therapeutics (BTAI) Announces Clinical Prioritization and Update on BXCL501
(NASDAQ: BTAI) Delayed: 1.06 --0 (-0%)
Previous Close $1.06    52 Week High
Open $1.06    52 Week Low
Day High $1.06    P/E N/A 
Day Low $1.06    EPS
Volume 13,923